cd 437 has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Ausubel, FM; Conery, AL; Fricke, N; Fuchs, BB; Gao, H; Gilmore, MS; Hendricks, GL; Keohane, CE; Kim, W; Lee, K; Mylonakis, E; Pan, W; Rajamuthiah, R; Shen, S; Steele, AD; Van Tyne, D; Vlahovska, PM; Wuest, WM; Zhu, W | 1 |
Barzago, MM; Carminati, P; Dallavalle, S; Diomede, L; Fratelli, M; Garattini, E; Giannì, M; Kurosaki, M; Merlini, L; Parrella, E; Pisano, C; Raska, I; Rochette-Egly, C; Tavecchio, M; Terao, M | 1 |
3 other study(ies) available for cd 437 and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
A new class of synthetic retinoid antibiotics effective against bacterial persisters.
Topics: Animals; Anti-Bacterial Agents; Benzoates; Caenorhabditis elegans; Cell Death; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Gentamicins; Humans; Lipid Bilayers; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Mutation; Naphthols; Retinoids; Staphylococcal Infections | 2018 |
Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamm
Topics: Adamantane; Animals; Antineoplastic Agents; Calcium; Cell Death; Cell Differentiation; Cells, Cultured; Chlorocebus aethiops; Cinnamates; COS Cells; Cytosol; Disease Models, Animal; G2 Phase; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, SCID; Mitosis; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; RNA, Messenger; Teratocarcinoma; Tretinoin | 2006 |